These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15694506)

  • 1. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler G; Riggs M; Griffith M; Fewlass C; Watts M; Hessel C; Cordova J; Glezen WP
    Vaccine; 2005 Feb; 23(13):1540-8. PubMed ID: 15694506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME; Piedra PA; Longini IM; Gaglani MJ; Schmotzer B; Fewlass C; Herschler GB; Glezen WP
    Vaccine; 2007 May; 25(20):4038-45. PubMed ID: 17395338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herd protection against influenza.
    Glezen WP
    J Clin Virol; 2006 Dec; 37(4):237-43. PubMed ID: 17008123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
    Gaglani MJ; Piedra PA; Herschler GB; Griffith ME; Kozinetz CA; Riggs MW; Fewlass C; Halloran ME; Longini IM; Glezen WP
    Arch Pediatr Adolesc Med; 2004 Jan; 158(1):65-73. PubMed ID: 14706961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures.
    Halloran ME; Longini IM; Gaglani MJ; Piedra PA; Chu H; Herschler GB; Glezen WP
    Am J Epidemiol; 2003 Aug; 158(4):305-11. PubMed ID: 12915495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
    King JC; Lichenstein R; Magder LS
    Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of influenza vaccine for healthy children in the US.
    Block SL
    Paediatr Drugs; 2004; 6(4):199-209. PubMed ID: 15339199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
    Piedra PA; Yan L; Kotloff K; Zangwill K; Bernstein DI; King J; Treanor J; Munoz F; Wolff M; Cho I; Mendelman PM; Cordova J; Belshe RB
    Pediatrics; 2002 Oct; 110(4):662-72. PubMed ID: 12359778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children: A Cluster Randomized Blinded Trial.
    Loeb M; Russell ML; Manning V; Fonseca K; Earn DJ; Horsman G; Chokani K; Vooght M; Babiuk L; Schwartz L; Neupane B; Singh P; Walter SD; Pullenayegum E
    Ann Intern Med; 2016 Nov; 165(9):617-624. PubMed ID: 27538259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model of influenza infection and vaccination in children aged under 5 years in Beijing, China.
    Zhang Y; Muscatello DJ; Cao Z; Chughtai AA; Costantino V; Zhang D; Yang P; Wang Q; MacIntyre CR
    Hum Vaccin Immunother; 2020 Jul; 16(7):1685-1690. PubMed ID: 31995439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.
    Tam JS; Capeding MR; Lum LC; Chotpitayasunondh T; Jiang Z; Huang LM; Lee BW; Qian Y; Samakoses R; Lolekha S; Rajamohanan KP; Narayanan SN; Kirubakaran C; Rappaport R; Razmpour A; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2007 Jul; 26(7):619-28. PubMed ID: 17596805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.